Adaptive Biotechnologies Corp reports results for the quarter ended in September - Earnings Summary

Adaptive Biotechnologies

03/11/2021 21:46

* Adaptive Biotechnologies Corp  ADPT.OQ  reported a quarterly
adjusted loss of 40 cents​​ per share for the quarter ended in
September. The mean expectation of eight analysts for the
quarter was for a loss of 42 cents per share.
* Revenue rose 50.1% to $39.47 million from a year ago; 
analysts expected $36.64 million. 
* Adaptive Biotechnologies Corp's reported EPS for the quarter
was a loss of 40 cents​.
* The mean earnings estimate of analysts had risen by about 0.6%
in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Adaptive Biotechnologies Corp shares had risen by 1.6% this
quarter and lost 41.6% so far this year.
* The company reported a quarterly loss of $55.9 million.
* Wall Street's median 12-month price target for Adaptive
Biotechnologies Corp is $54.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 3 at 09:46 p.m.
 ​All figures in US dollars unless otherwise stated